X0306 4 2016-02-08 0 0001479290 Revance Therapeutics, Inc. RVNC 0001597578 Ruegg Curtis C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 EVP, Technical Operations Common Stock 2016-02-08 4 M 0 1000 8.70 A 18264 D Common Stock 2016-02-08 4 S 0 1000 18.14 D 17264 D Employee Stock Option (Right to Buy) 8.70 2016-02-08 4 M 0 1000 0.00 D 2023-05-26 Common Stock 1000 52836 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Ruegg on March 16, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.25. Dr. Ruegg undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to this Option vest in 48 equal monthly installments over 4 years following May 27, 2013. /s/ Gordon Ho, Attorney-in-fact 2016-02-10